With minimal early-stage symptoms, lung cancer is the leading cause of cancer deaths. That’s why early detection through screening is essential to achieving better outcomes for patients.
Our Approach to Bronchoscopy
During stage 1 and 2, lung cancer nodules tend to be small and located deep in the periphery of the lung, making them difficult to detect with manual bronchoscopy. The Monarch™ platform, using robotic-assisted bronchoscopy, is a minimally invasive diagnostic tool that can detect and diagnose early stage lung cancer.
The platform uses a telescoping endoscope with computer-assisted navigation combining real-time vision of the lungs with advanced software and 3D modeling of the lung to offer deeper views of the patient’s lung. This results in deeper access and more complete visualization of all segments of the lung as well highly accurate targeting of tissue to biopsy. The procedure is similar to traditional bronchoscopy, however the robotic technology provides more advanced precision and control.
New at Inspira: Robotic Technology That Detects Lung Cancer Earlier
Inspira Medical Center Vineland was among the first 100 hospitals nationwide to adopt the Monarch platform.
What this means for your patients
With Monarch, patients experience fewer complications—including infection, bleeding, pain and false diagnoses—than other, more invasive procedures like transthoracic needle aspiration (TTNA). Patients who have small, peripheral nodules can now be diagnosed using Monarch’s minimally invasive procedure.
As a High Reliability Organization, safety is a top priority for Inspira patients and staff. We’re committed to providing the safest, most accurate and most advanced screening technology to our community.